Oura to Acquire Counsel Health for $625 Million, Bringing AI-Powered Primary Care and Personalized Healthcare to Members
ŌURA, the company behind the Oura Ring and a leading health intelligence platform, has entered into a definitive agreement to acquire Counsel Health, an artificial intelligence-powered primary care company founded by physicians and AI researchers. The acquisition represents a significant step in Oura’s strategy to expand beyond wearable health monitoring and deliver more connected, personalized, and proactive healthcare services.
Through this transaction, Oura aims to combine its continuous biometric monitoring technology with Counsel Health’s AI-powered medical platform and network of physicians. The integration is expected to give Oura Members access to a broader range of healthcare services directly through the Oura App, connecting personal health insights with medical guidance and clinical care.
The proposed combination reflects a growing shift in the healthcare industry toward technology-enabled care models that prioritize prevention, accessibility, and personalized treatment. While wearable devices have traditionally focused on tracking health indicators and providing insights into daily wellness, Oura is looking to take the next step by helping users translate those insights into meaningful healthcare decisions.
By integrating Counsel Health’s medical AI capabilities with Oura’s biometric data, the companies intend to create a more comprehensive healthcare experience. Members will be able to access personalized medical guidance based on their health information, ask questions about medical concerns, and connect with qualified physicians when professional clinical support is required.
The acquisition is designed to address a gap between understanding personal health and taking action. Wearable devices can provide valuable information about sleep, activity, recovery, and other physiological indicators. However, interpreting these measurements and determining whether medical attention is necessary can be challenging for consumers.
The integration of Counsel Health is expected to help bridge that gap by connecting continuous health monitoring with medical expertise.
Tom Hale, chief executive officer of Oura, said the partnership will allow members to move from understanding their physiological data to taking action across a wider range of healthcare needs.
He explained that the combined platform will support different healthcare requirements, ranging from answering everyday medical questions and obtaining prescriptions to understanding laboratory results, managing chronic conditions, and accessing referrals.
According to Hale, the objective is to develop a new model of care that extends beyond conventional healthcare experiences by making medical guidance more immediate, personalized, and proactive. He described the acquisition as an important milestone in Oura’s mission to empower individuals to live healthier and longer lives through technology-enabled access to healthcare.
Combining Continuous Health Monitoring with AI-Powered Medical Care
At the center of the acquisition is the integration of Oura’s biometric monitoring technology with Counsel Health’s AI-native primary care platform.
Oura has developed its business around helping individuals understand their health through continuous monitoring. Its smart ring collects biometric information that can provide insights into various aspects of personal well-being.
Counsel Health adds a clinical dimension to this technology by offering AI-supported medical guidance and access to physicians.
Under the planned integrated experience, members will be able to begin healthcare conversations in two ways. They can start with an insight generated by their Oura device or directly initiate a conversation with Counsel’s medical AI through the Oura App.
The AI platform will use available health information and relevant medical context to provide personalized guidance. If a medical concern requires additional evaluation, users will be able to escalate the conversation to a board-certified Counsel physician.
The companies say that access to a physician will be available within minutes when needed. Physicians will be able to provide appropriate clinical services, including diagnoses, prescriptions, and referrals.
This approach is intended to create a more convenient connection between digital health information and professional medical care. Instead of requiring users to interpret wearable data independently or navigate separate healthcare platforms, the combined service aims to bring these capabilities together in one application.
The companies also believe that continuous biometric information can make medical guidance more relevant. Longitudinal health measurements can help clinicians understand changes over time rather than relying exclusively on information collected during an individual appointment.
For example, changes in a person’s health indicators may provide additional context when evaluating a medical concern. When combined with medical history and clinical records, these measurements could help physicians develop a more informed understanding of an individual’s health.
Strong Early Feedback from Counsel Health Users
Oura and Counsel Health have already observed positive feedback from members using their combined services through their existing partnership.
According to the companies, more than 90% of surveyed members who used Counsel said their Oura data helped them receive better care.
Additionally, members who consulted a Counsel physician rated their healthcare experience an average of 4.6 out of 5.
These findings suggest that users value the combination of personal health information and access to medical professionals. The results also highlight the potential benefits of integrating wearable technology with digital healthcare services.
The companies believe that combining objective biometric measurements with physician-led care can improve the relevance and quality of medical interactions.
For patients, having access to their health information during a medical consultation may help them communicate concerns more effectively. For physicians, additional information about a patient’s health patterns may provide useful context when evaluating symptoms and considering treatment options.
However, the broader success of this model will depend on how effectively the technology integrates with existing healthcare systems and how consistently it delivers safe, reliable, and clinically appropriate guidance.
Counsel Health’s Physician-Led Medical AI Technology
Counsel Health was founded by Muthu Alagappan, MD, who serves as the company’s chief executive officer. The organization was developed by physicians and AI researchers with a focus on combining artificial intelligence with human medical expertise.
The company’s platform is built around a clinical AI harness that coordinates specialized artificial intelligence agents to support different stages of the healthcare process.
These agents perform specific tasks, including collecting medical histories, retrieving clinical guidelines, reviewing medical records, and identifying potential emergencies.
Rather than relying on a single general-purpose AI system to manage every aspect of a medical conversation, Counsel’s architecture uses specialized agents designed to perform individual clinical functions.
Each agent undergoes extensive evaluation to assess its performance, safety, and quality. The company also uses feedback from its physicians to improve the platform and strengthen its clinical capabilities.
This physician-guided development approach is intended to ensure that medical AI remains aligned with established healthcare practices and appropriate clinical standards.
When members begin a conversation with Counsel AI, the system can draw on several sources of information, including connected medical records, previous interactions, evidence-based clinical guidelines, and continuous biometric data.
This information allows the platform to provide guidance that reflects an individual’s health history and available clinical context.
Users can also request the involvement of a Counsel physician at any point during the conversation. When appropriate, the physician can evaluate the medical concern and provide clinical services such as diagnoses, prescriptions, and referrals.
The combination of AI support and human clinical oversight is central to Counsel’s approach. The company aims to use artificial intelligence to improve access and operational efficiency while maintaining physician involvement in important medical decisions.
AI-Powered Tools to Support Physician Decision-Making
In addition to the member-facing medical AI platform, Counsel Health has developed an internal technology interface called the Clinician Cockpit.
The Clinician Cockpit is an AI-native care delivery system designed to help physicians review patient information and make more informed clinical decisions.
The platform synthesizes a patient’s medical records and longitudinal health trends, presenting relevant information in a structured format. It also provides context-aware clinical suggestions that can support physicians during the care process.
By organizing medical information and highlighting relevant health patterns, the system aims to reduce the administrative burden associated with reviewing multiple sources of patient data.
Physicians can use the information to better understand a patient’s medical background, evaluate ongoing health concerns, and consider appropriate next steps.
This technology is particularly relevant as healthcare providers increasingly explore ways to incorporate artificial intelligence into clinical workflows.
Healthcare organizations often manage large volumes of medical information, including laboratory results, prescriptions, patient histories, and consultation records. Accessing and reviewing this information efficiently can be challenging.
AI-supported clinical tools may help organize these records and provide physicians with additional context. However, clinical judgment and physician oversight remain important components of the decision-making process.
Counsel’s Clinician Cockpit is designed to support that relationship by combining automated information synthesis with human medical expertise.
Three Major Areas of Healthcare Expansion
Following the acquisition, Oura and Counsel Health plan to expand their existing partnership across three major areas: preventive care, acute care, and specialty and chronic care.
These areas represent different stages of healthcare needs and are intended to create a more connected experience for members.
1. Preventive Care
Preventive healthcare will be one of the primary focus areas of the combined platform.
Oura’s continuous biometric monitoring capabilities can help members recognize changes in their health over time. By combining these measurements with Counsel’s medical guidance, the companies aim to help individuals take proactive steps when potential health concerns arise.
The approach is intended to encourage earlier awareness and more informed healthcare decisions.
Rather than waiting until symptoms become more serious, members may be able to use their health information to identify changes that warrant professional attention.
Clinical guidance can then help determine whether further evaluation, testing, or other healthcare services may be appropriate.
2. Acute Care
The second area of focus is acute care, which involves medical concerns that arise suddenly and may require timely attention.
Through the integrated platform, members will be able to access medical AI for initial guidance and connect with physicians when additional clinical support is needed.
This may include support for episodic health concerns, medical questions, and appropriate prescriptions.
The goal is to make healthcare access more convenient by reducing the time and effort required to obtain initial medical guidance.
For individuals who need professional evaluation, the platform is designed to provide a pathway to a qualified physician.
3. Specialty and Chronic Care
The third area will focus on specialty and chronic healthcare needs that require ongoing monitoring and management.
The companies plan to explore services covering areas such as reproductive health, aging, and cardiometabolic health.
These healthcare categories often require continued engagement between patients and healthcare professionals.
For example, people managing chronic conditions may need regular monitoring, medication guidance, follow-up consultations, and adjustments to their care plans.
By combining biometric information with medical records and physician access, Oura and Counsel aim to create a more continuous approach to managing these needs.
The integration could also provide members with a more convenient way to remain engaged with their healthcare between traditional medical appointments.
Counsel Health to Continue Serving Enterprise Partners
An important aspect of the acquisition is that Counsel Health will continue working with its existing and new enterprise partners following the transaction.
The company currently makes its services available through partnerships with health plans, health systems, consumer health organizations, and employers.
Oura and Counsel intend to build on these relationships to expand access to AI-native healthcare beyond Oura’s existing membership base.
This strategy could provide an opportunity to reach millions of additional patients through established healthcare and employer distribution networks.
For Counsel, the acquisition offers access to Oura’s technology platform, consumer relationships, and growing market presence. For Oura, the agreement introduces an additional healthcare service that can expand the value of its wearable technology.
The companies believe that combining consumer health monitoring with enterprise healthcare partnerships can help increase clinical capacity and improve access to affordable medical services.
Muthu Alagappan, MD, founder and chief executive officer of Counsel Health, said continuous health information makes medical AI more useful because it allows guidance to be tailored to each individual’s circumstances.
He emphasized that Counsel’s platform was developed around trust, safety, and responsible AI implementation, with physicians remaining involved in clinical decisions.
Alagappan also highlighted the value of Oura’s biometric information, explaining that continuous measurements and long-term health trends can give clinicians additional objective information when evaluating patients.
He described the acquisition as a natural extension of the shared vision between the two organizations and expressed enthusiasm about joining Oura to make high-quality healthcare more accessible across acute and chronic medical conditions.
Oura Announces $625 Million Acquisition Investment
The acquisition also represents a significant financial investment by Oura as it expands its healthcare strategy.
According to David Shuman, executive chairman of Oura, the company plans to invest $625 million in cash to acquire Counsel Health.
Shuman highlighted the company’s growth over the past decade, noting that Oura has expanded from a smart-ring manufacturer into a broader health intelligence platform.
He also pointed to Oura’s membership growth, which has surpassed six million members, as an important factor supporting the company’s ability to invest in new healthcare capabilities.
According to Shuman, Oura’s revenue increased by 153% during the latest fiscal quarter, providing the company with confidence to pursue the acquisition.
He explained that Oura helps members understand what is happening inside their bodies, while Counsel provides a way to take action based on those insights.
The combination is expected to expand Oura’s addressable market, strengthen the value of its services for existing members, and create opportunities to reach additional populations through Counsel’s enterprise partnerships.
Shuman also welcomed Alagappan and the Counsel Health team to Oura, describing the acquisition as an opportunity to bring together complementary technologies and healthcare expertise.
Record Financial Performance Supports Oura’s Expansion
The acquisition announcement follows a strong fiscal fourth quarter for Oura.
For the quarter ended September 30, 2026, the company reported preliminary and unaudited revenue of $533 million, representing 153% growth compared with the same period in the previous year.
Oura also reported continued year-over-year expansion in gross margin and generated $87 million in Adjusted EBITDA, representing an Adjusted EBITDA margin of 16%.
For fiscal year 2026, the company generated approximately $1.75 billion in revenue, representing year-over-year growth of 92%.
These financial results demonstrate the company’s expanding commercial performance and provide additional context for its decision to invest in healthcare services.
The company noted that the reported financial figures are preliminary and unaudited. They may change as Oura completes its year-end closing procedures and audit.
The strong performance also reflects the growing commercial importance of wearable health technology as consumers increasingly use connected devices to monitor personal health and wellness.
By adding medical AI and physician access, Oura is looking to expand its business beyond biometric tracking and establish a stronger position in the digital healthcare market.
Advancing the Future of Connected and Personalized Healthcare
The planned acquisition of Counsel Health represents a broader evolution in how wearable technology companies may participate in healthcare delivery.
Traditional wearable devices primarily provide information about physical activity, sleep, recovery, and other health indicators. However, the integration of medical AI and physician services introduces the possibility of connecting these insights with clinical guidance and ongoing healthcare support.
For consumers, the combined platform aims to offer a more direct connection between understanding personal health and obtaining appropriate medical assistance.
For healthcare professionals, access to longitudinal biometric data and organized medical records could provide additional context when evaluating patients.
For healthcare organizations and enterprise partners, AI-supported care delivery may offer new opportunities to expand access while making better use of clinical resources.
Nevertheless, the success of this approach will depend on maintaining patient privacy, protecting sensitive health information, ensuring clinical accuracy, and establishing appropriate medical oversight.
As artificial intelligence becomes increasingly integrated into healthcare, responsible implementation will remain essential to building patient trust and supporting safe medical decisions.
With more than six million members, strong financial growth, and a planned $625 million acquisition of Counsel Health, Oura is positioning itself to play a larger role in the connected healthcare ecosystem.
The combination of continuous biometric monitoring, AI-powered medical guidance, and access to physicians reflects the company’s ambition to move beyond health tracking toward a more comprehensive healthcare experience.
Ultimately, Oura and Counsel Health aim to make healthcare more immediate, personalized, and accessible by connecting everyday health insights with professional medical support. Through the acquisition, the companies are seeking to advance a model in which technology helps individuals better understand their health, take preventive action, and access appropriate care across different stages of life.
Source link: https://www.businesswire.com/
